Story Highlights Unveils breakthrough CRISPR CascadeTM platform Platform delivers best-in-class accuracy without need for target amplification, resulting in analytical turnaround time of < 1 minute and massive multiplexing capabilities Company’s leadership team includes renowned experts in research tools, diagnostics and protein engineering SAN DIEGO, Calif. — VedaBio, the biotechnology company leading a paradigm-shift in molecular […]
Range of Highly Selective Anti-Idiotypic Antibodies Now Includes Six Antibodies Specific to Dupilumab and its Biosimilars for Bioanalysis and Drug Monitoring HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, today extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of […]
IPSWICH, Mass. — Named in honor of the founder and first Chief Executive Officer of New England Biolabs (NEB®), Donald Comb, this annual lectureship recognizes those who have pioneered basic research, with substantial impact on molecular biology, to address issues affecting the world at large. This year’s honoree is Jo Handelsman, the Director of the Wisconsin […]
ATLANTA — Axion BioSystems, a leading life science tools company focused on advanced live-cell assay platforms, today announced the appointment of Julien Bradley as the company’s new Chief Executive Officer. With nearly 20 years of experience in biotechnology development, commercialization, and leadership, Bradley will build on Axion’s growth in the fields of stem cell research, immuno-oncology, cell-based therapies, […]
ESF AdvanCD™ is a 100% chemically defined, animal-origin-free, protein-free, serum-free insect cell culture medium for use in viral vector manufacturing, structural biology and other applications DAVIS, California – Expression Systems, an Advancion company, today introduced a new, chemically defined cell culture medium that offers exceptional performance while improving the consistency and efficiency of gene therapy and […]
CORNING. N.Y. — Corning Incorporated (NYSE: GLW) today announced that its vice chairman and corporate development officer, Lawrence D. McRae, who has been with the company for nearly four decades, will retire at the end of the year. McRae will continue in his current role and remain on Corning’s Senior Leadership Team until his retirement. “Larry has […]
The manufacturing facility in Pune will double Cytiva’s manufacturing capacity in India and the Experience Center will provide critical training programs to accelerate the development of novel therapeutics. According to Cytiva’s 2023 Global Biopharma Resilience Index, the manufacturing of biologics in India is likely to increase over the next three years. Cytiva’s manufacturing facility in […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an antibody discovery, option and license agreement with Bayer. Under the terms of the agreement, Twist Biopharma Solutions, a division of Twist Bioscience, will leverage its Library of Libraries to […]
Congenica platform to continue providing tertiary analysis for Whole Genome Sequencing Cambridge, United Kingdom – Congenica, a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale, today announces a two-year extension to their contract for the Hong Kong Genome Project (HKGP), the first large-scale genome sequencing initiative in […]
Getinge has today completed the previously announced acquisition of 100% of the shares in High Purity New England, Inc. On May 31, 2023, Getinge announced an agreement to acquire High Purity New England, Inc., a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. All conditions for the transaction and […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
